Atrial Fibrillation and Cancer
Carregando...
Citações na Scopus
11
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
FRONTIERS MEDIA SA
Citação
FRONTIERS IN CARDIOVASCULAR MEDICINE, v.8, article ID 590768, 5p, 2021
Resumo
Cancer patients have a higher risk of atrial fibrillation (AF) than general population, the pathophysiology mechanisms involves the pro inflammatory status of immune system in these patients and the exacerbated inflammatory response to cancer treatment and surgeries. Adequate management and prophylaxis for its occurrence are important and reduce morbidity and mortality in this population. There is a challenge in AF related to cancer to predict thromboembolic and bleeding risk in these patients, once standard stroke and hemorrhagic prediction scores are not validated for them. It is used CHA2DS2-VASc and HAS-BLED scores, the same as used in general population. In this review, we demonstrate correlated mechanisms to occurrence AF in cancer patients as well as therapeutic challenges in this population.
Palavras-chave
atrial fibrillation, cancer, anticoagulation, cardiotoxicity, drug-drug interaction
Referências
- Alexandre J, 2018, PHARMACOL THERAPEUT, V189, P89, DOI 10.1016/j.pharmthera.2018.04.009
- Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454
- Cheng WL, 2016, INT J CARDIOL, V219, P186, DOI 10.1016/j.ijcard.2016.06.009
- Chu G, 2019, BLOOD REV, V35, P59, DOI 10.1016/j.blre.2019.03.005
- Farmakis D, 2014, J AM COLL CARDIOL, V63, P945, DOI 10.1016/j.jacc.2013.11.026
- Fitzpatrick T, 2017, THROMB RES, V155, P101, DOI 10.1016/j.thromres.2017.05.006
- Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594
- Goriacko P, 2018, EUR J HAEMATOL, V100, P488, DOI 10.1111/ejh.13045
- Lopes RD, 2019, NEW ENGL J MED, V380, P1509, DOI 10.1056/NEJMoa1817083
- Lopez-Fernandez T, 2019, REV ESP CARDIOL, V72, P749, DOI 10.1016/j.rec.2019.03.019
- Melloni C, 2017, EUR HEART J, V3, P192, DOI 10.1093/ehjqcco/qcx004
- Mery B, 2017, INT J CARDIOL, V240, P196, DOI 10.1016/j.ijcard.2017.03.132
- Mosarla RC, 2019, J AM COLL CARDIOL, V73, P1336, DOI 10.1016/j.jacc.2019.01.017
- Qamar A, 2018, J AM COLL CARDIOL, V71, P2162, DOI 10.1016/j.jacc.2018.03.023
- Vedovati MC, 2018, INT J CARDIOL, V269, P152, DOI 10.1016/j.ijcard.2018.07.138